Cargando…

Challenges and strategies to research ethics in conducting COVID‐19 research

The number of research involving human subjects on coronavirus disease 2019 (COVID‐19) is surging, bringing challenges to the ethical review committee (ERC) in terms of reviewing speed and special ethical considerations under the pandemic. However, the existing ethical review system and regulations...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Xitao, Wang, Yanqiao, Gao, Tian, He, Qing, He, Yan, Yue, Rensong, You, Fengming, Tang, Jianyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280675/
https://www.ncbi.nlm.nih.gov/pubmed/32445288
http://dx.doi.org/10.1111/jebm.12388
_version_ 1783543771780087808
author Ma, Xitao
Wang, Yanqiao
Gao, Tian
He, Qing
He, Yan
Yue, Rensong
You, Fengming
Tang, Jianyuan
author_facet Ma, Xitao
Wang, Yanqiao
Gao, Tian
He, Qing
He, Yan
Yue, Rensong
You, Fengming
Tang, Jianyuan
author_sort Ma, Xitao
collection PubMed
description The number of research involving human subjects on coronavirus disease 2019 (COVID‐19) is surging, bringing challenges to the ethical review committee (ERC) in terms of reviewing speed and special ethical considerations under the pandemic. However, the existing ethical review system and regulations have their limitations to meet the demand for a prompt and efficient epidemic control. Since the research under the public health emergency is different from that carried out in familiar situations to design and implementation, the strategy for a satisfactory ERC response should balance the duty of protecting individual participants as well as the special public needs derived from the disease control. It is suggested that the ethical review‐related regulations need to be updated, and a unified supervision system to the overall ERC is required. ERC collaboration, capacity‐improving and efficiency‐improving measures need to be taken. With respect to the reviewing guidelines, it is suggested that the international norms should be explained with more consideration of the local condition and the exceptional circumstances in this public health emergency. A joint effort needs to be taken for better research conduction.
format Online
Article
Text
id pubmed-7280675
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-72806752020-06-09 Challenges and strategies to research ethics in conducting COVID‐19 research Ma, Xitao Wang, Yanqiao Gao, Tian He, Qing He, Yan Yue, Rensong You, Fengming Tang, Jianyuan J Evid Based Med Commentary The number of research involving human subjects on coronavirus disease 2019 (COVID‐19) is surging, bringing challenges to the ethical review committee (ERC) in terms of reviewing speed and special ethical considerations under the pandemic. However, the existing ethical review system and regulations have their limitations to meet the demand for a prompt and efficient epidemic control. Since the research under the public health emergency is different from that carried out in familiar situations to design and implementation, the strategy for a satisfactory ERC response should balance the duty of protecting individual participants as well as the special public needs derived from the disease control. It is suggested that the ethical review‐related regulations need to be updated, and a unified supervision system to the overall ERC is required. ERC collaboration, capacity‐improving and efficiency‐improving measures need to be taken. With respect to the reviewing guidelines, it is suggested that the international norms should be explained with more consideration of the local condition and the exceptional circumstances in this public health emergency. A joint effort needs to be taken for better research conduction. John Wiley and Sons Inc. 2020-05-22 2020-05 /pmc/articles/PMC7280675/ /pubmed/32445288 http://dx.doi.org/10.1111/jebm.12388 Text en © 2020 The Authors. Journal of Evidence‐Based Medicine published by Chinese Cochrane Center, West China Hospital of Sichuan University and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Ma, Xitao
Wang, Yanqiao
Gao, Tian
He, Qing
He, Yan
Yue, Rensong
You, Fengming
Tang, Jianyuan
Challenges and strategies to research ethics in conducting COVID‐19 research
title Challenges and strategies to research ethics in conducting COVID‐19 research
title_full Challenges and strategies to research ethics in conducting COVID‐19 research
title_fullStr Challenges and strategies to research ethics in conducting COVID‐19 research
title_full_unstemmed Challenges and strategies to research ethics in conducting COVID‐19 research
title_short Challenges and strategies to research ethics in conducting COVID‐19 research
title_sort challenges and strategies to research ethics in conducting covid‐19 research
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280675/
https://www.ncbi.nlm.nih.gov/pubmed/32445288
http://dx.doi.org/10.1111/jebm.12388
work_keys_str_mv AT maxitao challengesandstrategiestoresearchethicsinconductingcovid19research
AT wangyanqiao challengesandstrategiestoresearchethicsinconductingcovid19research
AT gaotian challengesandstrategiestoresearchethicsinconductingcovid19research
AT heqing challengesandstrategiestoresearchethicsinconductingcovid19research
AT heyan challengesandstrategiestoresearchethicsinconductingcovid19research
AT yuerensong challengesandstrategiestoresearchethicsinconductingcovid19research
AT youfengming challengesandstrategiestoresearchethicsinconductingcovid19research
AT tangjianyuan challengesandstrategiestoresearchethicsinconductingcovid19research